Warren Point Capital, LLC is a venture capital firm that identifies and acquires minority positions in medical technology companies led by outstanding management teams who have a committment to developing and commercializing novel technologies.
Investment Type: Venture Capital
Portfolio 12
| Date | Name | Website | Total Raised | Location |
| - | Alto | alto.com | $500M | United Sta... |
| - | Promaxo | promaxo.com | $9.87M | United Sta... |
| - | SUTURE TEC... | suturetech.com | - | - |
| - | Contraline | contraline.com | $17.9M | United Sta... |
| - | Pocket Nal... | pocketnaloxone.com | - | - |
| - | GT Medical... | gtmedtech.com | $199.4M | United Sta... |
| - | allergenis.com | - | - | |
| - | Palette Li... | palettelifesciences.com | $40M | Sweden, St... |
| - | Rivia Heal... | riviahealth.com | $6.5M | United Sta... |
| - | Calyxo | calyxoinc.com | $82.8M | United Sta... |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 19.08.2024 | Revolutionizing Healthcare: Moximed and PayZen Lead the Charge | In the evolving landscape of healthcare, two companies are emerging as beacons of innovation: Moximed and PayZen. Both are tackling significant challenges in the medical field, albeit from different angles. Moximed is addressing the physica... |
| 17.08.2024 | Moximed: $91 Million (Series D) Closed To Improve Knee Osteoarthritis Care | Moximed, an innovative medical device company with a goal of improving the standard of care for people with knee osteoarthritis (OA), announced the closing on $61 million of Series D preferred stock financing with an option to close on up t... |